Cytomedix Announces Extension of Exclusivity Period to Global Pharmaceutical Company for Autologel System in Chronic Wound Marke

Regenerative therapies company Cytomedix announced an extension of the exclusivity period and an agreement with the top 20 globa... [more]

View complete Press Release article